Syros Pharmaceuticals, Inc. (SYRS) Ownership
SYRS ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 26.8M
- Float
- 26.8M shares available to trade
- Short interest
- 17.01% 913K shares short
- Days to cover
- 0.09 short interest up 26.3% vs prior month
- Other investors 100.00%
SYRS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 10.25% | 2.8M | $1,100 | — | December 31, 2024 |
| 2 | BlackRock Inc | 1.03% | 277K | $111 | +15,674 (+6.0%) | December 31, 2024 |
| 3 | Vanguard Group Inc | 1.00% | 268K | $107 | −685,159 (−71.9%) | December 31, 2024 |
| 4 | Omega Fund Management LLC | 0.94% | 251K | $101 | — | December 31, 2024 |
| 5 | Geode Capital Management, LLC | 0.73% | 196K | $79 | −8,443 (−4.1%) | December 31, 2024 |
| 6 | Affinity Asset Advisors, LLC | 0.56% | 150K | $60 | +150,000 (0.0%) | December 31, 2024 |
| 7 | Citigroup Inc | 0.52% | 139K | $56 | +138,537 (+20,165.5%) | December 31, 2024 |
| 8 | Qube Research & Technologies | 0.46% | 122K | $49 | +44,458 (+57.2%) | December 31, 2024 |
| 9 | TWO SIGMA SECURITIES, LLC | 0.40% | 108K | $43 | +107,742 (0.0%) | December 31, 2024 |
| 10 | Renaissance Technologies Corp | 0.36% | 96K | $38 | −393 (−0.4%) | December 31, 2024 |
| 11 | HRT FINANCIAL LLC | 0.33% | 88K | $35 | +87,535 (0.0%) | December 31, 2024 |
| 12 | XTX Topco Ltd | 0.30% | 81K | $33 | +52,626 (+182.5%) | December 31, 2024 |
| 13 | State Street Corp | 0.26% | 69K | $28 | — | December 31, 2024 |
| 14 | Jane Street Group LLC | 0.20% | 53K | $21 | +52,920 (0.0%) | December 31, 2024 |
| 15 | Two Sigma Investments LLC | 0.18% | 49K | $20 | +20,386 (+71.6%) | December 31, 2024 |
| 16 | UBS Group AG | 0.17% | 45K | $18 | +28,322 (+169.3%) | December 31, 2024 |
| 17 | Northern Trust Corp | 0.15% | 41K | $16 | — | December 31, 2024 |
| 18 | 1492 Capital Management, LLC | 0.15% | 39K | $16 | — | December 31, 2024 |
| 19 | Virtu Financial LLC | 0.12% | 33K | $13 | +13,162 (+67.1%) | December 31, 2024 |
| 20 | Baader Bank INC | 0.08% | 22K | $9 | +22,092 (0.0%) | December 31, 2024 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 733K shares and 3 cut 694K.
SYRS top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Institutional Extnd Mkt Idx Tr | 0.96% | 258K | $103 | — | January 31, 2025 |
| 2 | Fidelity Extended Market Index | 0.36% | 98K | $39 | −1,064 (−1.1%) | January 31, 2025 |
| 3 | iShares Micro-Cap ETF | 0.17% | 46K | $18 | — | February 28, 2025 |
| 4 | Extended Equity Market Fund K | 0.17% | 45K | $18 | −616 (−1.4%) | December 31, 2024 |
| 5 | Fidelity Total Market Index | 0.15% | 40K | $16 | — | January 31, 2025 |
| 6 | Fidelity Series Total Market Index | 0.09% | 24K | $9 | — | January 31, 2025 |
| 7 | Northern Trust Extended Eq Market Idx | 0.08% | 23K | $9 | — | December 31, 2024 |
| 8 | NT Ext Equity Mkt Idx Fd - L | 0.08% | 23K | $9 | — | December 31, 2024 |
| 9 | NT Ext Equity Mkt Idx Fd - NL | 0.06% | 17K | $7 | — | December 31, 2024 |
| 10 | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 0.05% | 13K | $5 | −220 (−1.6%) | December 31, 2024 |
| 11 | Spartan Total Market Index Pool E | 0.04% | 12K | $5 | — | January 31, 2025 |
| 12 | Vanguard U.S. Eq Idx £ Acc | 0.04% | 11K | $4 | — | January 31, 2025 |
| 13 | Fidelity Nasdaq Composite Index | 0.03% | 7,332 | $3 | — | January 31, 2025 |
| 14 | State St US Extended Mkt Indx NL Cl C | 0.03% | 6,833 | $3 | — | February 28, 2025 |
| 15 | Extended Equity Market Fund M | 0.02% | 5,812 | $2 | +56 (+1.0%) | December 31, 2024 |
| 16 | NT Ext Eq Mkt Indx Fd DC Lend T3 | 0.02% | 5,386 | $2 | +5,386 (0.0%) | December 31, 2024 |
| 17 | NT Ext Eq Mkt Indx Fd DC Lend T4 | 0.02% | 5,386 | $2 | +5,386 (0.0%) | December 31, 2024 |
| 18 | 1290 VT Micro Cap K | 0.02% | 4,840 | $2 | — | January 31, 2025 |
| 19 | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 0.01% | 3,488 | $1 | +6 (+0.2%) | September 30, 2024 |
| 20 | SSgA U.S. Total Market Index Strategy | 0.01% | 2,803 | $1 | +2,101 (+299.3%) | June 30, 2024 |
Funds report holdings monthly or quarterly; dates differ by fund.
SYRS insider transactions
latest 7| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-02 | Nancy A Simonian | Sell | $0.27 | 37,070 | $10,009 |
| 2024-11-25 | Nancy A Simonian | Sell | $0.27 | 134,713 | $36,373 |
| 2024-09-12 | Jason Haas | Buy | $1.68 | 45,344 | $76,178 |
| 2024-09-10 | Conley Chee | Buy | $1.51 | 50,000 | $75,500 |
| 2024-09-10 | Jason Haas | Buy | $1.55 | 35,363 | $54,813 |
| 2024-06-28 | Richard A Young | Sell | $5.12 | 34,837 | $178,365 |
| 2024-04-02 | David Roth | Sell | $4.98 | 150 | $747 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
SYRS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SYRS
Institutional investors own 0.0% of Syros Pharmaceuticals's shares and insiders 0.00%. The largest holder is Bain Capital Life Sciences Investors, LLC with 10.25% of the shares (2.8M), as of December 31, 2024. Among the top 20 institutions, 12 added shares and 3 reduced their stake in the latest filings. Short interest is 17.01% of the float, or 0.09 days of average trading volume. The share count rose 24,181.4% since 2014.
Related: SYRS analyst forecast, SYRS key metrics. See the SYRS stock overview for the latest quote and news.
SYRS ownership FAQ
Who owns the most Syros Pharmaceuticals stock?
The largest shareholders of Syros Pharmaceuticals are Bain Capital Life Sciences Investors, LLC (10.25%), BlackRock Inc (1.03%), Vanguard Group Inc (1.00%), Omega Fund Management LLC (0.94%), Geode Capital Management, LLC (0.73%).
What percentage of Syros Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of Syros Pharmaceuticals's shares outstanding; insiders hold 0.00%.
Which funds own Syros Pharmaceuticals?
The largest fund holders of Syros Pharmaceuticals are Vanguard Institutional Extnd Mkt Idx Tr (0.96%), Fidelity Extended Market Index (0.36%), iShares Micro-Cap ETF (0.17%), Extended Equity Market Fund K (0.17%), Fidelity Total Market Index (0.15%).
What is Syros Pharmaceuticals's short interest?
913K shares of Syros Pharmaceuticals were sold short, 17.01% of the float; at the average daily volume it would take 0.09 days to cover.
Are insiders buying or selling Syros Pharmaceuticals?
Of the latest 7 reported insider transactions in Syros Pharmaceuticals (since April 2, 2024), 3 were purchases and 4 were sales.
How many shares of Syros Pharmaceuticals are outstanding?
Syros Pharmaceuticals has 26.8M shares outstanding, of which 26.8M are in the public float.